vs

Side-by-side financial comparison of Cipher Mining Inc. (CIFR) and Organogenesis Holdings Inc. (ORGO). Click either name above to swap in a different company.

Cipher Mining Inc. is the larger business by last-quarter revenue ($59.7M vs $37.2M, roughly 1.6× Organogenesis Holdings Inc.). On growth, Cipher Mining Inc. posted the faster year-over-year revenue change (41.4% vs -57.1%). Over the past eight quarters, Cipher Mining Inc.'s revenue compounded faster (11.4% CAGR vs -46.5%).

Cipher Mining, Inc. operates as a Bitcoin mining ecosystem in the United States. The firm is developing a cryptocurrency business.

Organogenesis Holdings Inc. is a leading regenerative medicine firm specializing in developing and manufacturing advanced therapeutic products for wound care, surgical repair, sports medicine, and dermatology. It serves healthcare providers and patients primarily in the U.S. and select international markets, offering clinically validated solutions for unmet medical needs.

CIFR vs ORGO — Head-to-Head

Bigger by revenue
CIFR
CIFR
1.6× larger
CIFR
$59.7M
$37.2M
ORGO
Growing faster (revenue YoY)
CIFR
CIFR
+98.5% gap
CIFR
41.4%
-57.1%
ORGO
Faster 2-yr revenue CAGR
CIFR
CIFR
Annualised
CIFR
11.4%
-46.5%
ORGO

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
CIFR
CIFR
ORGO
ORGO
Revenue
$59.7M
$37.2M
Net Profit
$-734.2M
Gross Margin
59.4%
30.8%
Operating Margin
-503.4%
-185.1%
Net Margin
-1229.6%
Revenue YoY
41.4%
-57.1%
Net Profit YoY
-4293.1%
EPS (diluted)
$-1.91

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CIFR
CIFR
ORGO
ORGO
Q1 26
$37.2M
Q4 25
$59.7M
$225.6M
Q3 25
$71.7M
$150.9M
Q2 25
$43.6M
$101.0M
Q1 25
$49.0M
$86.7M
Q4 24
$42.2M
$126.7M
Q3 24
$24.1M
$115.2M
Q2 24
$36.8M
$130.2M
Net Profit
CIFR
CIFR
ORGO
ORGO
Q1 26
Q4 25
$-734.2M
$43.7M
Q3 25
$-3.3M
$21.6M
Q2 25
$-45.8M
$-9.4M
Q1 25
$-39.0M
$-18.8M
Q4 24
$17.5M
$7.7M
Q3 24
$-86.8M
$12.3M
Q2 24
$-15.3M
$-17.0M
Gross Margin
CIFR
CIFR
ORGO
ORGO
Q1 26
30.8%
Q4 25
59.4%
Q3 25
62.7%
Q2 25
64.8%
Q1 25
69.6%
72.6%
Q4 24
56.9%
75.5%
Q3 24
37.5%
76.7%
Q2 24
61.2%
77.6%
Operating Margin
CIFR
CIFR
ORGO
ORGO
Q1 26
-185.1%
Q4 25
-503.4%
28.1%
Q3 25
-52.5%
13.7%
Q2 25
-103.9%
-12.5%
Q1 25
-77.8%
-30.9%
Q4 24
40.5%
8.1%
Q3 24
-379.2%
5.4%
Q2 24
-43.9%
-10.7%
Net Margin
CIFR
CIFR
ORGO
ORGO
Q1 26
Q4 25
-1229.6%
19.4%
Q3 25
-4.6%
14.3%
Q2 25
-105.1%
-9.3%
Q1 25
-79.6%
-21.7%
Q4 24
41.5%
6.1%
Q3 24
-359.9%
10.7%
Q2 24
-41.5%
-13.1%
EPS (diluted)
CIFR
CIFR
ORGO
ORGO
Q1 26
Q4 25
$-1.91
$0.31
Q3 25
$-0.01
$0.11
Q2 25
$-0.12
$-0.10
Q1 25
$-0.11
$-0.17
Q4 24
$0.04
$0.05
Q3 24
$-0.26
$0.09
Q2 24
$-0.05
$-0.13

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CIFR
CIFR
ORGO
ORGO
Cash + ST InvestmentsLiquidity on hand
$628.3M
$91.4M
Total DebtLower is stronger
$2.7B
Stockholders' EquityBook value
$805.5M
Total Assets
$4.3B
$520.0M
Debt / EquityLower = less leverage
3.37×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CIFR
CIFR
ORGO
ORGO
Q1 26
$91.4M
Q4 25
$628.3M
$93.7M
Q3 25
$1.2B
$63.7M
Q2 25
$62.7M
$73.1M
Q1 25
$23.2M
$110.0M
Q4 24
$5.6M
$135.6M
Q3 24
$25.3M
$94.3M
Q2 24
$122.6M
$89.9M
Total Debt
CIFR
CIFR
ORGO
ORGO
Q1 26
Q4 25
$2.7B
Q3 25
$1.0B
Q2 25
$167.1M
Q1 25
Q4 24
$0
Q3 24
$62.3M
Q2 24
$63.8M
Stockholders' Equity
CIFR
CIFR
ORGO
ORGO
Q1 26
Q4 25
$805.5M
$300.1M
Q3 25
$783.2M
$255.1M
Q2 25
$748.9M
$233.2M
Q1 25
$734.8M
$242.9M
Q4 24
$682.0M
$262.9M
Q3 24
$672.0M
$278.5M
Q2 24
$690.8M
$263.5M
Total Assets
CIFR
CIFR
ORGO
ORGO
Q1 26
$520.0M
Q4 25
$4.3B
$598.7M
Q3 25
$2.8B
$509.8M
Q2 25
$1.0B
$461.1M
Q1 25
$913.8M
$467.4M
Q4 24
$855.4M
$497.9M
Q3 24
$775.4M
$446.3M
Q2 24
$775.6M
$443.2M
Debt / Equity
CIFR
CIFR
ORGO
ORGO
Q1 26
Q4 25
3.37×
Q3 25
1.31×
Q2 25
0.22×
Q1 25
Q4 24
0.00×
Q3 24
0.22×
Q2 24
0.24×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CIFR
CIFR
ORGO
ORGO
Operating Cash FlowLast quarter
$-207.9M
Free Cash FlowOCF − Capex
$-695.9M
FCF MarginFCF / Revenue
-1165.4%
Capex IntensityCapex / Revenue
817.1%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-1.1B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CIFR
CIFR
ORGO
ORGO
Q1 26
Q4 25
$-207.9M
$39.4M
Q3 25
$-50.1M
$3.1M
Q2 25
$-56.2M
$-32.9M
Q1 25
$-47.2M
$-19.9M
Q4 24
$-87.5M
$10.9M
Q3 24
$-6.5M
$8.7M
Q2 24
$-25.4M
$4.7M
Free Cash Flow
CIFR
CIFR
ORGO
ORGO
Q1 26
Q4 25
$-695.9M
$34.8M
Q3 25
$-256.2M
$844.0K
Q2 25
$-87.5M
$-36.5M
Q1 25
$-71.8M
$-23.6M
Q4 24
$-227.0M
$7.6M
Q3 24
$-83.2M
$6.1M
Q2 24
$-33.2M
$2.9M
FCF Margin
CIFR
CIFR
ORGO
ORGO
Q1 26
Q4 25
-1165.4%
15.4%
Q3 25
-357.3%
0.6%
Q2 25
-200.9%
-36.1%
Q1 25
-146.7%
-27.2%
Q4 24
-537.6%
6.0%
Q3 24
-345.0%
5.3%
Q2 24
-90.2%
2.2%
Capex Intensity
CIFR
CIFR
ORGO
ORGO
Q1 26
Q4 25
817.1%
2.1%
Q3 25
287.5%
1.5%
Q2 25
71.8%
3.6%
Q1 25
50.2%
4.2%
Q4 24
330.4%
2.7%
Q3 24
317.8%
2.2%
Q2 24
21.4%
1.4%
Cash Conversion
CIFR
CIFR
ORGO
ORGO
Q1 26
Q4 25
0.90×
Q3 25
0.14×
Q2 25
Q1 25
Q4 24
-5.00×
1.43×
Q3 24
0.71×
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons